Bibliografía

Effects of mifepristone (RU-486) on heme metabolism and cytochromes P-450 in cultured chick embryo liver cells, possible implications for acute porphyria

Câble EE, Pepe JA, Donohue SE, Lambrecht RW, Bonkovsky HL
Eur J Biochem. 1994; 225 (2): 651-657

Mifepristone and prostaglandin for termination of pregnancy: contraindications for use, reasons and rationale

Davey A
Contraception. 2006 Jul; 74 (1): 16-20

Verifying the effectiveness of medical abortion; ultrasound versus hCG testing

Fiala C, Safar P, Bygdeman M, Gemzell-Danielsson K
Eur J Obstet Gynecol Reprod Biol. 2003; 109 (2): 190-195

Vasospastic angina pectoris following abortion induced byprostaglandin analogue

Lindhardt TB, Walker LR, Colov NS, Hansen PS
Ugeskr Laeger. 2000; 162 (48): 6536-6537

Effects of mifepristone in vivo on decidual prostaglandin synthesis and metabolism

Norman JE, Wu WX, Kelly RW, Glasier AF, McNeilly AS, Baird DT
Contraception. 1991; 44: 89

Anti-progesterones in obstetrics, ectopic pregnancies and gynaecological malignancies

Ulmann A, Dubois C
Baillieres Clin Obstet Gynaecol. 1988; 2 (3): 631-638

Prostanoid receptors involved in the relaxation of human pulmonary vessels

Walch L, Labat C, Gascard JP, de Montpreville V, Brink C, Norel X
Br J Pharmacol 1999; 126: 859-866

Mifepristone: a review of its pharmacodynamic and pharmaco-kinetic properties, and therapeutic potential

Brogden RN, Goa KL, Faulds D
Drugs. 1993; 45(3): 384-409

Effects of the antiprogesterone RU 486 in normal women.II. Administration in the late follicular phase

Shoupe D, Mishell DR Jr, Page MA, Madkour H, Spitz IM, Rogerio AL
Am J Obstet Gynecol. 1987; 157: 1421-1426

Effects of the antiprogesterone steroid RU 486 during mid-luteal phase in normal women

Schaison G, George M, Lestrat N, Reinberg A, Baulieu EE
J Clin Endocrinol Metab. 1985; 61: 484-489

Effects of an antiprogesterone(RU 486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle

Garzo VG, Liu J, Ulmann A, Baulieu EE, Yen SSC
J Clin Endocrinol Metab. 1988; 66: 508-517

Management of patients receiving long-term treatment with mifepristone

Spitz IM, Grunberg SM, Chabbert-Buffet N, Lindenberg T, Gelber H, Sitruk-Ware R
Fertil Steril. 2005; 84(6): 1719-1726

The effect of luteectomy-induced progesterone withdrawal on the oxytocin and prostaglandin response of the first trimester pregnant human uterus

Csapo AI, Pulkkinen MO, Kaiholo HL
Prostaglandins. 1973; 4: 421-429

The effect of the antiprogestins RU486 and ZK98734 on the synthesis and metabolism of prostaglandins F2-alpha and E2 in separated cells from early human decidua

Smith SK, Kelly RW
J Clin Endocrinol Metab. 1987; 65: 527-534

Progesterone receptor blockage. Effect on uterine contractility and early

Bygdeman M, Swahn ML
Contraception. 1985; 32: 45-51

Efficacy of progesterone antagonist RU 486 (mifepristone) for pre-operative cervical dilation during first trimester abortion

Durlot F, Dubois C, Brunerie J, Frydman R
Hum Reprod. 1988; 3: 583-584

The effects of RU-38486 on cervical ripening. Clinical studies

Lefebvre Y, Proulx L, Elie R, Poulin O, Lanza E
Am J Obstet Gynecol. 1990;162(1): 61-65

Mifepristone-induced nitric oxide release and expressionof nitric oxide synthase in the human cervix during early pregnancy

Vaisanen-Tommiska M, Butzow R, Ylikorkala O, Mikkola TS
Hum Reprod. 2006; 21: 2180-2184

Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary

Rodger MW, Baird DT
Lancet. 1987; 2: 1415-1418

The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486)

el-Refaey H, Hinshaw K, Templeton A
Hum Reprod. 1993; 8 (10): 1744-1746